Press Releases

Valencell to Demo V-LINC™ Health and Fitness Earbud Sensor Technology at 2012 International CES

January 4, 2012 — Company to perform live demos of accurate, continuous, real-time, biometric data streamed to multiple mobile platforms at booth N3638 Read More

Valencell to Showcase Breakthrough Continuous HeartRate Monitoring Technology at CTIA ENTERPRISE & APPLICATIONS™ 2011

September 27, 2011 — Valencell, an innovator in mobile health and fitness technology, today announced it will unveil new prototypes with extended capabilities at CTIA ENTERPRISE & APPLICATIONS™ 2011. Read More

Valencell, Inc. Expands Executive Team with Addition of Todd Ackman, VP of Finance

September 13, 2011 — Valencell, an innovator in mobile health and fitness technology, announced today the addition of Todd Ackman, Vice President of Finance, to its growing team.  Todd brings extensive financial experience to Valencell, having led fundraising and M&A execution for Inlet Technologies, Inc. Read More

Valencell, Inc. Announces $5.5 Million Series B Venture Financing

June 20, 2011 — Valencell, an innovator in mobile health and fitness technology, announced today that it has received $5.5 million in Series B venture investment. The round was led by Best Buy Capital, the investment group of Best Buy Co., Inc., with participation from Series A investors TDF and True Ventures. Read More

Dr. Steven LeBoeuf, cofounder and CEO of Valencell, a featured panelist at CED

April 27, 2011 — Dr. Steven LeBoeuf, cofounder & CEO of Valencell, will be a featured panelist at CED’s "All Things Tech" Venture Conference on Wednesday April 27th. Read More

Valencell awarded $1.1M NIH SBIR Phase II Grant: April 3rd, 2011

April 3, 2011 — NIH SBIR Grant # 2R44DK083141-02: Valencell has been awarded a $1.1M NIH SBIR Phase II grant to clinically validate a scalable and seamless energy expenditure monitoring platform for accurately measuring caloric consumption and expenditure in mass markets. Read More

Valencell, a featured presenter at the 5th Annual Southeast Venture Conference in Atlanta, Georgia, March 2-3, 2011

March 8, 2011 — Dr. Steven LeBoeuf, cofounder and CEO of Valencell, will be presenting at SEVC 2011 in Atlanta. The Southeast Venture Conference highlights both early stage and later stage investment opportunities from: Alabama, Florida, Georgia, Maryland, Mississippi, North Carolina, South Carolina, Tennessee, Virginia and Washington DC. Read More

Valencell wins Phase 2 award for developing mobile, wearable, multiwavelength blood analyte sensor

December 20, 2010 — Valencell has been granted an NSF Phase 2 STTR Award for developing a mobile, wearable, noninvasive blood analyte sensor that can be worn throughout everyday life activit Read More

Valencell & Rensselaer Polytechnic Institute (RPI) win collaborative NIH award

December 20, 2010 — Valencell has won a collaborative NIH award to integrate RPI's daysimetry technology into Valencell's Healthset® platform. Read More

Vital signs monitoring through your Bluetooth headset

December 20, 2010 — Press Release: Valencell's Healthset® technology allows you to track your vital signs while wearing a wireless headset, such as a Bluetooth audio headset. Read the press release here... Read More

Pages